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Introduction  
Atrial fibrillation (AF) is the most common supraventricular arrhythmia in 
humans. Arrhythmogenic thoracic veins have been implicated not only in 
the initiation, but also in the perpetuation of atrial fibrillation. Pulmonary 
vein isolation is a mainstay technique of treatment of paroxysmal AF (PAF), 
however, ablation of persistent atrial fibrillation may require adjunctive 
methods of substrate modification. Both ablation targeting complex 
fractionated atrial electrograms (CFAE) recorded during AF and 
fractionated electrograms recorded during sinus rhythm (SRF) have been 
described but the relationship of CFAE to SRF is unclear.  
Accurate mapping and representation of atrial rate throughout the atria 
during AF because sites of high atrial rate might represent structures critical 
to AF initiation and maintenance and amenable to ablation. 
One possible way to achieve that is by measuring and averaging the cycle 
length (CL) of atrial activation at different sites across the atria in the time 
domain, however CFAEs frequently present a major obstacle to accurate CL 
measurement. Therefore another approach that is gaining popularity is to 
use spectral analysis of atrial electrograms which can be helpful when 
presenting spatial distribution of atrial rate in arrhythmias such as AF that 
show some irregularity in CL or signal amplitude. 
Beyond the electrical considerations of AF, the potential mechanical 
consequences are also important and multiple factors contribute to 
functional mitral regurgitation (MR) in patients with AF. The relationship 
between AF associated left atrial (LA) remodeling, and its influence on the 
mitral apparatus have not been investigated. 
Objectives 
1. To elucidate the relationship between the distribution of 
CFAE/fragmented areas in the LA during AF and fragmented areas during 
SR, and analyse the mechanism of electrogram fractionation during SR. 
2. To test our hypothesis that AF control after radiofrequency ablation 
(RFA) would result in reduction in MR by facilitating beneficial remodeling 
of the LA and mitral apparatus. 
3. Using spectral analysis of AF, to investigate the distribution of dominant 
frequencies (DFs) in the atria and pulmonary veins (PVs) during PAF and 
the response to arrhythmogenic PV isolation. 
 
Methods 1. 
Patients undergoing ablation of persistent AF were included in the study. 
Decapolar catheters were placed in the posterior right atrium (RA) and 
coronary sinus. A circular mapping catheter (10-pole, adjustable 15–25-mm 
Lasso, 6-mm bipole spacing, Biosense Webster, Diamond Bar, CA, USA) 
and a 3.5-mm tip irrigated ablation catheter (Celcius Thermocool, Biosense 
Webster; Diamond Bar CA) were introduced in the LA through double 
transseptal puncture.  
 
CFAE maps 
A three-dimensional LA geometry was created using the NavX 
electroanatomic mapping system (NavX, St. Jude Medical, St. Paul, MN). 
After the geometry was created, a detailed bipolar LA CFAE map was 
acquired during AF using the circular mapping catheter. The CFAE map 
was acquired on-line using automated NavX algorithm.  
 
Sinus Rhythm Fractionation Map 
After DC cardioversion to sinus rhythm followed by a 5-minute waiting 
period, a second detailed bipolar LA activation map was acquired in SR, 
using the same circular mapping catheter. Care was taken to assure an even 
distribution of points throughout the left atrial geometry. Sinus rhythm 
fractionation (SRF) was calculated manually for each electrogram by 
counting the number of deflections present in each electrogram and 
recoding the total number of deflections as the peak-to-peak voltage. In this 
manner, a color-coded sinus rhythm “fractionation map” could be displayed. 
Normal conduction typically results in three deflections of the bipolar 
electrogram. In order to determine a cutoff for the number of deflections 
that was considered  “abnormal,” we determined the 95th percentile of 
electrogram deflections from our nine patient normal controls, after 
excluding septal points which have both right and left atrial components. 
We found that  95% of bipolar electrograms showed ≤ 5 deflections in our 
healthy control population, therefore electrograms with more than five 
deflections were defined as abnormally fragmented.  
A frequency domain measure of left atrial sinus rhythm bipolar electrogram 
fractionation was also used. The "FFT ratio” (Fast Fourier Transformation 
ratio, FFTr ) of high(>100 Hz) to total (0-300 Hz) spectral power was 
automatically computed and displayed on the electroanatomic map using a 
customized version of the NavX software. We found that an FFT ratio 
cutoff of >20% identified areas of fractionated electrograms during sinus 
rhythm. 
 
Left Atrial Activation Maps During Sinus Rhythm and Coronary Sinus 
Pacing 
The high density sinus rhythm maps also allowed a detailed reconstruction 
of left atrial endocardial activaton. Regions of SRF were outlined on the LA 
geometry and activation patterns in regions of SR fractionation were 
examined in order to determine the mechanisms of fractionation. We 
hypothesized that areas of sinus rhythm fractionation might be related to 
wavefront collision. Finally, we also altered the pattern of wavefront 
propagation by pacing from the distal coronary sinus and repeating a third 
detailed bipolar activation map during coronary sinus pacing. The overlap 
between regions of LA fractionation recorded during CS pacing and regions 
of wavefront collision during CS pacing was calculated.  
 
Control group 
In order to determine the distribution of SRF in normal controls, 
nine control subjects without structural heart disease or history of AF 
underwent detailed bipolar LA maps in SR (CARTO XP, Biosense Webster, 
Diamond Bar, CA). These patients had all undergone mapping and ablation 
of paroxysmal supraventricular tachycardia  
 
Quantitative analysis 
The LA surface was divided into 9 segments: left pulmonary veins, 
right pulmonary veins, roof, septum, anterior wall, lateral wall, posterior 
wall, left atrial appendage and mitral annulus (extending 1 cm from the 
mitral valve plane). Each AF CFAE region, each SR fractionation region 
and each CS pacing fractionated region was outlined. The percentage of 
each anatomic segment that was encompassed by each fractionated region 
was calculated for each map. The percent overlap between CFAE and SRF 
was counted as the area common to both CFAE and SRF divided by the 
total area of CFAE. CFAE and SRF data were also exported to SPSS to 
calculate a correlation coefficient between maps.  
The percent overlap between the fractionated areas on the manual and 
automated FFtr maps was calculated as the area common to both regions 
divided by the total area of SRF in each segment. The percentage of areas of 
wavefront collision that were within regions of fractionation  (# collisions 
within fractionated area / total # collisions) was calculated for the sinus 
rhythm and CS pacing maps. 
 
Voltage analysis 
Since the voltage characteristics of normal human LA are not well defined, 
we measured the global and regional unipolar (UNI) and bipolar (BI) signal 
amplitudes in the control patients to determine the optimal voltage cutoff 
for the normal left atrium. These data served as a standard for comparing 
the regional distribution of low voltage areas in AF population and controls. 
Finally, we analyzed the voltage in regions of SRF in AF patients compared 
to healthy controls.  
 
Methods 2. 
We performed a retrospective cohort study to determine whether AF is 
associated with significant atrial functional MR.  
Reports from transthoracic echocardiograms performed within 3 days of 
catheter ablation of AF were screened, and an experienced research 
echocardiographer analyzed the images of those with greater than mild MR. 
All patients with secondary Type I MR of at least moderate severity and 
who also had complete 1-year clinical follow-up after ablation were 
included in the MR cohort. The reference cohort was randomly selected in a 
1-to-1 fashion from those patients with mild or less MR on initial report 
screening and subsequent image analysis and who also had complete 1-year 
clinical follow-up. Patients with an ejection fraction <50% were excluded to 
avoid including patients whose MR  might be due to ventricular dysfunction. 
Demographic and clinical information were prospectively obtained in all 
patients. The clinical AF syndrome was determined based on the 
predominant arrhythmia presentation at the time of admission and was 
defined as paroxysmal if AF episodes were self-terminating in < 7 days and 
persistent if typical AF episodes lasted >7 days and/or required intervention 
for termination. 
 
Ablation procedure  
 
All patients underwent proximal antral PVI, guided by intracardiac 
echocardiogram and circular multipolar electrode catheter recordings and 
elimination of all provocable PV triggers and all non-PV triggers resulting 
in AF. All 4 PVs were isolated routinely in patients with a history of 
persistent AF, those without provocable AF triggers, and those patients with 
significant risk factors for AF including a history of hypertension, LA 
enlargement, and those over the age of 50 years. In the  remaining selected 
patients, we isolated arrhythmogenic  PVs only.  
 
 
Patient follow-up 
 
Patients were clinically evaluated as outpatients at 6 to 12 weeks, 6 months, 
and 1 year, at which time they were queried for symptoms and 12-lead 
electrocardiograms were obtained. Echocardiograms were performed at the 
first visit and at the  second or third visits, at the treating physician’s 
discretion. Antiarrhythmic medications were typically discontinued at 6 to 
12 weeks if patients had paroxysmal AF and at 6 months if they had 
persistent AF, but were continued beyond this point in selected patients 
based on doctor and/or patient preference even in the absence of an 
arrhythmia event. The patients were provided with a transtelephonic 
monitor (TTM) and instructed to transmit 2 times daily and with symptoms 
during the first 4 weeks after ablation. They were then instructed to transmit 
once at 6 to 12 weeks, then once at 6 months and 1 year. Patients also made 
additional TTM transmission if they had any arrhythmia symptoms at any 
time during follow-up and/or when antiarrhythmic medications were 
discontinued. One-year AF recurrence was defined according to consensus 
guidelines as any documented electrocardiographic episode of atrial 
arrhythmia lasting 30 s or longer with or without symptoms. Recurrence at 
the  time of follow-up echocardiography was defined as any 
electrocardiographic recurrence during the 6 months preceding the 
echocardiogram. 
 
Echocardiography 
 
Standard 2-dimensional and Doppler echocardiography with color flow 
mapping was performed according to the standard clinical protocol. 
Echocardiograms were then analyzed offline by a single research 
echocardiographer, blinded to patient outcomes and to the relative timing of 
the echocardiogram. LA anterior–posterior systolic diameter was measured 
in the parasternal long-axis view, and the major axis of the LA was 
measured in the apical 4-chamber view. LA area at endsystole was 
measured in the apical 2- and 4-chamber views. Similarly, LA volumes at 
end-systole were measured in the apical 2- and 4-chamber views using a 
single-plane modified Simpson’s method of discs, and values averaged. 
Mitral annular dimensions were measured in parasternal long-axis, apical 2-
chamber, and apical long-axis views. MR color jet area was measured in the 
apical 4-chamber, apical 2-chamber, and apical long-axis views. Color 
Doppler scale and, therefore, Nyquist limit were determined by the clinical 
ultrasonographer and in general were set to 50 to 70 cm/s. The ratio of MR 
color jet area to LA area (MR/LA ratio) was then calculated, using the 
largest  measured values for both. Mild MR was defined as a 
MR/LA ratio of ≥0.1 to ≤0.2, moderate MR as ≥0.2 to ≤0.4, and severe as 
≥0.4. Only patients with moderate or greater MR were included in the MR 
cohort. Leaflet motion was characterized as normal, excessive, or restrictive 
Only patients with normal mitral leaflet motion (Carpentier  Type I) were 
included in the MR cohort. Patients with any  evidence of primary leaflet 
involvement, such as from prior endocarditis, rheumatic valve disease, 
congenital anomaly, or significant mitral annular calcification, were 
excluded. 
 
Methods 3. 
 
To test the spectral analysis of AF we aimed to characterize the dominant 
frequency (DF) distribution in the atria and PVs shortly after initiation and 
during sustained paroxysmal AF in relation to the specific arrhythmogenic 
structure triggering the episode.Test patients were included if they had 
frequent episodes of PAF resistant to at least one antiarrhythmic medication. 
Exclusion criteria were previous catheter ablation for PAF, non-paroxysmal 
AF, previous heart surgery involving atriotomy, severe valvular heart 
disease, LA thrombosis and/or contraindications to prolonged 
anticoagulation..  
 
Electrophysiological study and follow-up 
 
Following femoral venous access decapolar steerable electrophysiologic 
catheters (interelectrode spacing 2-5-2 mm, Dynamic Deca, Bard 
Electrophysiology, Lowell, MA, USA) were positioned in the CS and at the 
posterolateral RA wall with the distal bipole at the junction between the RA 
and superior vena cava (SVC). After double transseptal puncture a 
decapolar circular mapping catheter ( Inquiry Optima, St. Jude Medical, 
Irvine, CA, USA ) and a quadripolar, 3,5 mm irrigated tip mapping/ablation 
catheter (Navistar Thermocool, Biosense Webster, California, USA) were 
advanced to the LA. Intracardiac echocardiography (ICE) (AcuNav, Acuson 
Corp, Mountain View, CA, USA) was used to define the PV ostia and to 
guide catheter positioning. Initially, the circular mapping catheter was 
positioned at the left PV antrum and the mapping/ablation catheter was 
steered to the carina between the right PVs. If the patient presented to the 
EP lab in sinus rhythm PAF induction was attempted by isoproterenol 
infusion at a starting dose of 3 µg/min with subsequent increments of 5 
µg/min until PAF was induced, the patient developed side effects or the 
maximum dose of 20 µg/min was reached. 
If the presenting rhythm was AF transthoracic electrical cardioversion was 
performed before proceeding to AF induction. Atrial premature 
depolarizations (APDs) identified as PAF triggers were recorded using the 
above mentioned catheter configuration and the endocardial activation 
sequence was analyzed. Early activation at the poles positioned in the 
superior or inferior regions of the left antrum with LA-PV electrogram 
reversal was considered to signify left superior (LSPV) or left inferior 
pulmonary vein (LIPV) origin of the APDs, respectively.to determine their 
origin Triggers demonstrating early activation at the poles located at the 
level of the left carina were considered to arise from the left PVs without 
further specifying their origin to the LSPV or LIPV. APDs were considered 
to arise from the right PVs if the earliest activation during APD was 
recorded at the right PV carina and the quadripolar catheter positioned there 
demonstrated distal to proximal activation and/or LA-PV potential reversal. 
When earliest atrial activation was recorded at any of the CS or RA bipoles 
these structures were identified as triggers. Upon induction of sustained AF 
isoproterenol infusion was discontinued and further signal recordings were 
made after a 5 min waiting period. During sustained AF the circular catheter 
was used to record signals sequentially from each PV ostium and the LA 
posterior wall (LAPW) simultaneously with recordings from the RA and CS. 
After achieving stable catheter position as assessed by fluoroscopy and ICE, 
signals were recorded for at least 30 sec from all catheter bipoles at a 
sampling rate of 997 Hz/sec using a commercially available digital EP 
recording system (GE Cardiolab, General Electrics, Milwaukee, WI, USA). 
 
 
Signal analysis 
Intracardiac signals were analysed utilizing a custom designed 
computer application prepared with the LabView software package 
(National Instruments, Austin, Texas). Signals were bandpass filtered 
between 30 and 500 Hz, rectified and then low-pass filtered at 20 Hz. 
Following this preprocessing a FFT with a Hanning window was performed 
on two consecutive 5-seconds episodes of the signal from each bipole from 
all catheters (frequency resolution 0.2 Hz). The frequency spectrum in the 
3-15 Hz range was obtained and the DF was determined as the peak with 
the highest power. Regularity index (RI) was also calculated as the ratio of 
the area under the DF peak and its harmonics to the area under the whole 
spectrum curve in the above mentioned frequency range The maximum DF 
value from all bipoles of each structure was taken as the DF of that structure 
and used for further analysis   
 
Results 1 
 
Twenty patients with persistent AF were included in the study. 
 
Comparison of AF CFAE and SR Fractionation Maps 
An average of 418 ± 135, and 338 ± 150 points were acquired for 
the CFAE and SRF maps, respectively. CFAE comprised 25 ±15% of the 
LA surface area. CFAE regions were most prevalent on the LA septum 
(37%), anterior wall (44%) the roof of LA (45%), and least prevalent in the 
LAA (14 %). SR fractionation encompassed 29 ±14% of the left atrium. SR 
fractionation was most prevalent on the LA septum (53%) and anterior wall 
(45 %), and least prevalent in the LAA (12%). 
Despite the similar general distributions of the two different measures of 
electrogram fractionation, the location of the actual SRF and CFAE regions 
were typically different, with only 32±16% overlap. There was also no 
significant correlation between SR fractionation and CFAE maps (r=0.2 p= 
0.24). 
 On the other hand, the appearance of the manual SR fractionation and 
automated FFTr maps was quite similar, with abnormal electrograms using 
both techniques comprising 29±14 and 31±12 % of the LA surface area, 
respectively. There was a significant correlation between SRF, and FFTr 
maps (r=0.6 p<0.01) with 75 % overlap between the SRF and FFTr maps.   
 
SR Fractionation and Wavefront Collision 
Analyzing the  left atrial endocardial activaton using the high 
density sinus rhythm maps, areas of wavefront collision were encompassed 
by regions of SRF  75±13% of the time. When activation maps were then 
repeated during coronary sinus pacing at 500ms, there was a shift in the 
areas of wavefront collision. Along with these shifts in areas of wavefront 
collision during CS pacing, there was a parallel shift in regions of 
electrogram fractionation such that there continued to be an 87± 13 % 
overlap between areas of fractionation during CS pacing and regions of 
wavefront collision This suggests that the majority of the regions of sinus 
rhythm fractionation, whether recorded during sinus rhythm or CS pacing, 
were due to wavefront collision rather than some inherent characteristic of 
the local atrial tissue. 
 
Control group 
 In 9 patients with structurally normal hearts, detailed SRF maps 
were acquired. In normal atria, SRF was most prevalent on the LA septum 
(65%) and anterior wall (49%), and least prevalent in the LA appendage 
(8%). SRF in patients with AF and controls comprised 29±14% and 
32±20% of the LA surface area, respectively. There was no significant 
difference in the distribution of SRF between the 9 healthy control patients 
and the 20 patients with a history of AF(p=0.74) 
 
Voltage characteristics 
 In control patients, the global mean LA BI and UNI voltage 
amplitude in SR were 2.83±2.25 mV and 4.12±2.14 mV, respectively; 95% 
of all BI and UNI electrograms recorded from the LA were >0.50 and >1.57 
mV, respectively.  
There was no difference in mean LA BI voltage between the AF patients 
and the controls (2.80 ± 2.75 mV vs 2.83 ± 2.25 mV; p= 0.68). Using the 
0.5 mV as a BI voltage cutoff indicating abnormal atrial substrate, we 
calculated the percentage of low voltage areas (<0.5 mV) in each LA 
segment (excluding the pulmonary veins) in AF patients and normal 
subjects. In healthy controls, low voltage signals were present rarely in the 
LA septum (1%), roof (2%), anterior wall (2%), posterior wall (3%), lateral 
wall (4%), mitral annulus (4%), and LA appendage (0%). There was no 
difference in the segmental distribution of low voltage areas between AF 
patients and healthy controls (p=0.829). 
 
Results 2 
 
There were 97 patients who met our criteria for significant MR after study 
review. Of these, 54 had normal leaflet motion with no apparent primary 
leaflet pathology (6.5% of all patients undergoing first ablation), 53 of 
whom had 1-year clinical follow-up and were included as the MR cohort. 
One patient required mitral valve surgery in the first year after ablation, but 
after her 6-month echocardiogram, and was included in the analyses. Of the 
660 patients with mild or less MR and 1-year clinical follow-up, 53 patients 
were randomly selected as the reference cohort.  
Patients with MR were older, more likely to have persistent AF, and more 
frequently had hypertension. Ninety-seven percent of patients were in sinus 
rhythm at the time of their baseline echocardiogram. Patients with MR had 
significantly larger LA size by several measures and larger mitral annular 
dimensions, but no difference in any measure of left ventricular size or 
function. Among the reference cohort, 60% had trace or no MR and 40% 
had mild MR. In the MR cohort, 72% had moderate MR and 28% had 
severe MR. Binary logistic regression models were constructed to 
determine the variables that were independently associated with significant 
MR. Mitral annular dimension had the largest odds ratio in the final model 
(8.39 per cm, 95% CI: 1.94 to 36.35 per cm, p = 0.004). 
 
 
Follow-up echocardiography 
Follow-up echocardiograms were available in 32 of the 53 patients in the 
MR cohort, an average of 277 days after ablation.. Rhythm status at follow-
up was defined as described above, applied only to the 6 months preceding 
echocardiography. By this definition, 21 patients were free of recurrence 
and 11 patients had recurrence of AF. Ninety-four percent of patients were 
in sinus rhythm at the time of follow-up echocardiography. At the time of 
ablation, patients with eventual recurrence had larger measures of LA size 
(LA volume index: 41.3 cm3/m2 vs. 28.2 cm3/m2, p = 0.02), with 
nonsignificant trends towards larger regurgitant jet area and mitral annular 
dimension. Other echocardiographic measures were not significantly 
different between the 2 groups at baseline. 
At follow-up, both groups had reductions in LA size, but only the group in 
sinus rhythm had a significant decrease in mitral annular dimension (3.41 
cm at baseline to 3.24 cm at follow-up, p = 0.02). Both groups experienced 
some decrease in MR, but at follow-up, the patients in sinus rhythm had 
significantly less MR than patients with AF recurrence (MR/LA ratio: 0.16 
vs. 0.28, p = 0.005) (Table 4), despite being similar at baseline. At baseline 
both groups had similar percentages of patients with moderate and severe 
MR (p = 0.72). At follow-up, 19% of the patients in sinus rhythm had trace 
or no MR, compared with 0% in the recurrence group, and 57% in the sinus 
rhythm group had mild MR compared with 18% in the recurrence group. 
Only 24% of the sinus rhythm patients still had significant MR at follow-up, 
compared with 82% in the recurrence group (p = 0.005 for entire trend). 
 
Results 3 
 
Isoproterenol infusion at a dose of 11.05 ± 4.76 µg/min led to induction of 
sustained AF in 26 patients (93%) that were further studied.  
PAF was triggered by APDs from the PVs in 24 patients and from the 
SVC/RA junction in two. PV triggers were found to originate from the 
LSPV in 11 (42.3 %), from the LIPV in 2 (7.7 %), from the right PVs in 4 
(15.4%). In 7 (26.9%) the trigger was localized to the carina region between 
LSPV and LIPV.  
The arrhythmogenic structures had the highest DF in 22 patients (84.6%) 
This includes the two patients with RA trigger in whom the highest DF was 
found in the RA  In the remaining patients a slightly higher DF was 
recorded from non-arrhythmogenic PVs. In the recording there was a 
significant difference in the DF among the arrhythmogenic structures, the 
PVs, the LAPW,  the CS and the RA (8.07 ± 1.5 Hz vs. 6.65 ± 1.36 Hz vs. 
6.06 ± 0.7 Hz vs. 6.01 ± 0.68 Hz vs. 5.93 ± 0.78 Hz, respectively, p < 
0.0001). The pairwise analysis showed a significantly higher DF in the 
arrhythmogenic structures compared to the PVs (mean difference 1.42 ± 
0.27 Hz, p < 0.0001), LAPW (mean difference 2.02 ± 0.32 Hz, p < 0.0001), 
CS (mean difference 2.07 ± 0.32 Hz, p < 0.0001),  and RA (mean difference 
2.15 ± 0.35 Hz, p < 0.0001). 
Among the 24 patients with PV triggers spontaneous termination occurred 
in 5 (21%) patients. Acute termination during ablation was observed in 14 
(74%) of the remaining 19 patients. Nine of the 14 patients (64%) had AF 
termination upon isolating the arrhythmogenic PV antrum. The arrhythmia 
continued despite arrhythmogenic PV isolation in 10 of 19 patients (53%). 
Contralateral PV antrum isolation as a second step resulted in AF 
termination in 5 patients (26%). Another 5 patients were cardioverted after 
all PVs were isolated. One of them needed additional lesions for complete 
PV isolation. 
 
Discussion 
 
1. In our study of patients with persistent AF, we found that 1) there is little 
correlation between the location of CFAE recorded during AF and 
fractionated electrograms recorded during sinus rhythm 2) fractionated 
electrograms recorded during sinus rhythm are mainly caused by wavefront 
collision in the LA and 3) the presence and distribution of sinus rhythm 
fractionation in patients with a history of AF is the same as in control 
patients without a history of AF. Finally, we also found that a signal 
processing measure, the FFT ratio, closely approximated a manual measure 
of sinus rhythm fractionation. Together, these findings imply that 
fractionated electrograms recorded during sinus rhythm, whether measured 
in the time or frequency domain, are a normal finding in the human LA due 
to wavefront collision, and are not evidence of underlying tissue 
characteristics that serve to maintain AF.  
 
2. The results of our retrospective cohort study demonstrated, that 
frequency of mild to moderate or more severe MR is more common in the 
unique population undergoing AF ablation comparing to historical controls.. 
Second ,after a successful AF ablation procedure, the LA size and 
dimensions, mitral annular diameters and consequently, the degree of 
functional MR decreased significantly in a subset of AF patients presented 
with mild to moderate or more severe MR at baseline in contrast with 
patients with failed procedure. 
We refer to this as atrial functional MR, and clinical characteristics 
associated with this MR were older age, hypertension, and most powerfully, 
persistent rather than paroxysmal AF. By echocardiography, MR was 
associated with increased LA size and mitral annular dilation. After 
multivariate regression, we found that only age, persistent AF, and mitral 
annular dilation were linked to MR. This suggests that LA size, notably not 
independently correlated with MR, may mediate its impact via its effect on 
the mitral annulus. 
By studying follow-up echocardiograms after AF ablation, we were able to 
evaluate possible pathophysiological mechanisms underlying atrial 
functional MR. Patients with successful ablations experienced significant 
reductions in LA size and mitral annular dimension, and less than a third 
still had significant MR at follow-up. In contrast, among patients who had 
recurrence of AF, there was no significant change in annular dimension 
despite near-significant reductions in LA size. Over 80% of the patients 
with recurrence still had significant MR at follow-up. These findings, 
combined with those from our regression model, which showed that mitral 
annular dimension was the only independent echocardiographic predictor of 
MR, strongly suggest that atrial functional MR is mediated through a 
process of annular dilatation. Based upon this observation, it can be 
assumed that beyond the regression of dilated chambers, the potential 
recovery of the mechanical function can be beneficial on the active motion 
of mitral leaflets 
3. This study demonstrates that in most patients with PAF the 
arrhythmogenic structures show the highest DF peak during spectral 
analysis. Moreover, termination of PAF by ablation occurs most frequently 
during isolation of arrhythmogenic PVs. Due to wave breakdown and 
emergence of complex block pattern multiple, well-demarcated DF domains 
are formed in the atria as a hallmark of fibrillatory conduction These 
domains are spatially distributed in a hierarchical order with the highest DF 
located in the LA and the lowest in the RA. 
Studies using frequency mapping during AF in both animal models and 
humans also support the role of PVs in AF maintenance showing the 
highest DF to be recorded at the PVs  
The presence of a DF gradient from the LA to RA has been shown by Lazar 
et al. in patients with PAF but not in those with persistent AF. This gradient 
is abolished with PV isolation and has been found to recover in patients 
undergoing repeat procedures due to arrhythmia recurrence  
Conclusion 
 
1 There is little overlap between regions of CFAE recorded during AF and 
regions of SR fractionation. During sinus rhythm, fractionated electrograms 
typically occur in regions of wavefront collision. There is no significant 
difference in the frequency and distribution of fractionated electrograms 
recorded during sinus rhythm in patients with and without AF. These 
findings suggest SRF is not a surrogate for CFAE during AF ablation and 
SRF itself may not be a suitable ablation target. 
 
2 Patients with AF and significant MR with AF control after RFA had 
significant reduction in LA dimensions, mitral annular size and MR. These 
observations suggest a potential relationship between atrial fibrillation and 
functional mitral regurgitation due to atrial enlargement and annular dilation, 
and these detrimental effects can be reversed with control of AF after RFA 
 
3 Frequency analysis is a feasible technique which can reliably identify the 
arrhythmogenic structures which should be the main targets of ablation 
therapy in PAF patients. Triggering structures show the highest activation 
rate during PAF, suggesting their  major role not only in the initiation but 
also in the maintenance of human AF.  
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